Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection
about
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infectionsPopulation dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments.Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocolsPharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.In vitro pharmacodynamic models to determine the effect of antibacterial drugs.Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli.Once-daily gentamicin administration for community-associated methicillin resistant Staphylococcus aureus in an in vitro pharmacodynamic model: preliminary reports for the advantages for optimizing pharmacodynamic index.In vitro bactericidal activity of enrofloxacin against gyrA mutant and qnr-containing Escherichia coli isolates from animals.Aerosolized recombinant human lysozyme enhances the bactericidal effect of tobramycin in a hamster model of Pseudomonas aeruginosa-induced pneumonia.Aerosolized recombinant human lysozyme ameliorates Pseudomonas aeruginosa-induced pneumonia in hamsters.Pharmacodynamics of non-replicating viruses, bacteriocins and lysins.Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics.
P2860
Q33767602-84128AF3-1633-42BD-BA49-E86714AA2C36Q34045319-BD31CA9B-C7F7-45E8-9602-6C6A2EB683CFQ34387384-51AEE85B-C57C-43AF-97E4-995F771ACB07Q37568933-F41A6F5D-D9F3-4E76-9CFC-D1196B8E6C94Q37660762-DEA7B366-17A0-4F98-8D9A-20AB20879F0DQ39376296-859CC6A6-D82F-40A2-BACA-25A1E702EC5DQ40666822-34717112-ADA1-4335-B17A-9974F8113394Q41877860-9EEF8FAE-916B-4C01-8C71-0D8532CC6647Q45564582-4070EF69-427C-4004-B157-4F3C9CD98D59Q51764788-15EDA85C-AD51-41DD-A307-23AFE1FBE4E8Q51774620-43AE599E-284C-4122-A9E1-29D8D2A62EAAQ51932254-8E18F932-6B5F-491B-8C03-E507B568515DQ52655481-34A18352-7449-43F8-9934-CC5F0F5C827B
P2860
Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Determination of antibiotic ef ...... shed animal model of infection
@ast
Determination of antibiotic ef ...... shed animal model of infection
@en
Determination of antibiotic ef ...... shed animal model of infection
@nl
type
label
Determination of antibiotic ef ...... shed animal model of infection
@ast
Determination of antibiotic ef ...... shed animal model of infection
@en
Determination of antibiotic ef ...... shed animal model of infection
@nl
prefLabel
Determination of antibiotic ef ...... shed animal model of infection
@ast
Determination of antibiotic ef ...... shed animal model of infection
@en
Determination of antibiotic ef ...... shed animal model of infection
@nl
P2093
P2860
P1476
Determination of antibiotic ef ...... shed animal model of infection
@en
P2093
Charles R Bonapace
John A Bosso
Lawrence V Friedrich
Roger L White
P2860
P304
P356
10.1128/AAC.46.11.3574-3579.2002
P407
P577
2002-11-01T00:00:00Z